REFERENCES

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.

2. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomarkers Prev 2016;25:16-27.

3. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 2017;26:444-57.

4. Weigelt B, Peterse JL, van ‘t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005;5:591-602.

5. Nielsen HM, Overgaard M, Grau C, Jensen AR, et al; Danish Breast Cancer Cooperative Group. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006;24:2268-75.

6. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116-26.

7. Hasan T, Ortel B, Solban N, Pogue BW. Photodynamic therapy of cancer. 7th edition. Hamilton, Ontario: BC Decker, Inc.; 2006. pp. 537-48.

8. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010;110:2795-838.

9. Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Letters 2012;326:8-16.

10. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-8.

11. Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S, et al. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 1996;14:59-66.

12. Ahmad N, Mukhtar H. Mechanism of photodynamic therapy-induced cell death. Methods Enzymol 2000;319:342-58.

13. Ortel B, Shea CR, Calzavara-Pinton P. Molecular mechanisms of photodynamic therapy. Front Biosci (Landmark Ed) 2009;14:4157-72.

14. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56:125-43.

15. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol 2003;120:325-31.

16. Campbell SM, Tyrrell J, Marshall R, Curnow A. Effect of MAL-photodynamic therapy on hypertrophic scarring. Photodiagnosis Photodyn Ther 2010;7:183-8.

17. Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol 2004;11:322-7.

18. Allison RR, Sibata C, Mang TS, Bagnato VS, Downie GH, et al. Photodynamic therapy for chest wall recurrence from breast cancer. Photodiagnosis Photodyn Ther 2004;1:157-71.

19. Liu Y, Hou G, Zhang X, Liu JJ, Zhang S, et al. A pilot randomized clinical study of the additive treatment effect of photodynamic therapy in breast cancer patients with chest wall recurrence. J Breast Cancer 2014;17:161-6.

20. Maytin EV, Anand S, Riha M, Lohser S, Tellez A, et al. 5-Fluorouracil enhances protoporphyrin IX accumulation and lesion clearance during photodynamic therapy of actinic keratoses: a mechanism-based clinical trial. Clin Cancer Res 2018;24:3026-35.

21. Sinha AK, Anand S, Ortel BJ, Chang Y, Mai Z, et al. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 2006;95:485-95.

22. Anand S, Honari G, Hasan T, Elson P, Maytin EV. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res 2009;15:3333-43.

23. Anand S, Wilson C, Hasan T, Maytin EV. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. Cancer Res 2011;71:6040-50.

24. Anand S, Rollakanti KR, Brankov N, Brash DE, Hasan T, et al. Fluorouracil enhances photodynamic therapy of squamous cell carcinoma via a p53-independent mechanism that increases protoporphyrin IX levels and tumor cell death. Mol Cancer Ther 2017;16:1092-101.

25. Rollakanti KR, Anand S, Maytin EV. Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer. Cancer Med 2015;4:633-42.

26. Anand S, Hasan T, Maytin EV. Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors. Mol Cancer Ther 2013;12:1638-50.

27. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998;34:1274-81.

28. Yasuno H, Kurasawa M, Yanagisawa M, Sato Y, Harada N, et al. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes. Oncol Rep 2013;29:451-8.

29. Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005;27:23-44.

30. Venturini M. Rational development of capecitabine. Eur J Cancer 2002;38:3-9.

31. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008;8:228.

32. Duan X, Chan C, Guo N, Han W, Weichselbaum RR, et al. Photodynamic therapy mediated by nontoxic core-shell nanoparticles synergizes with immune checkpoint blockade to elicit antitumor immunity and antimetastatic effect on breast cancer. J Am Chem Soc 2016;138:16686-95.

33. Kolinsky K, Zhang YE, Dugan U, Heimbrook D, Packman K, et al. Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts. Anticancer Res 2009;29:91-8.

34. Toi M, Masuda N, Lee SJ. Capecitabine for primary breast cancer. Oncotarget 2017;8:110739-40.

35. Toi M, Masuda N, Ohashi Y. Adjuvant capecitabine for breast cancer. N Engl J Med 2017;377:791-2.

36. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-61.

37. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016;7:27-31.

38. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8.

39. Anand S, Rollakanti KR, Horst RL, Hasan T, Maytin EV. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma. Photochem Photobiol 2014;90:1126-35.

40. Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001; doi: 10.1002/0471142735.im2002s39.

41. Paschall AV, Liu K. An orthotopic mouse model of spontaneous breast cancer metastasis. J Vis Exp 2016; doi: 10.3791/54040.

42. Longo JP, Muehlmann LA, Miranda-Vilela AL, Portilho FA, de Souza LR, et al. Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model. J Biomed Nanotechnol 2016;12:689-99.

43. Kim JB, Urban K, Cochran E, Lee S, Ang A, et al. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 2010;5:e9364.